tiprankstipranks
Intensity Therapeutics reports Q3 EPS (25c), consensus (30c)
The Fly

Intensity Therapeutics reports Q3 EPS (25c), consensus (30c)

As of September 30, cash and cash equivalents totaled $2.8M, which the company expects will be sufficient to fund operations into the first quarter in 2025.

Pick the best stocks and maximize your portfolio:

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App